Labs / ADME, DMPK & toxicology
셀트리온 Celltrion
Incheon, South Korea · celltrion.com
GMP
On your own
Free. Their own form.
Through Midgard
Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.
Celltrion develops, manufactures, markets, and sells biopharmaceuticals, biosimilars, small molecules, and novel therapeutics. It operates from Incheon, South Korea, with production facilities in Songdo and a plant in Branchburg, New Jersey, and serves global markets including North America, Europe, Asia, and South America.
Their website has a general contact form; we send your quote request through it.
What they offer
Antibody biopharmaceutical R&D
Develops biopharmaceuticals including novel antibody discoveries, biosimilar development, novel therapeutics development, and platform technology development.
Small molecule R&D
Develops new chemical entities, generic products, chemical IMDs, and platform technologies for small molecules.
Candidate antibody screening
Screens candidate antibodies and develops target product profiles.
Cell line development
Develops high-expression cell lines and secures intellectual property rights to source technologies.
Process development
Develops cell culture and purification processes and optimizes processes for commercial manufacturing.
Analytical method development
Develops analytical methods based on A-QbD and studies physicochemical and biological properties, similarity, stability, mechanism of action, and bioanalytical methods.
Formulation development
Carries out preliminary formulation development, formulation characterization studies, delivery device development, and primary container closer system studies.
Pharmacology and toxicology
Conducts pharmacokinetics, pharmacodynamics, and toxicology studies.
Biopharmaceutical manufacturing
Manufactures drug substances and drug products at biopharmaceutical production facilities.
Contract manufacturing
Operates the Branchburg plant as a contract manufacturing site for external clients.
Distribution
Provides distribution as one of its business areas.
What they work on
- Modalities
- Small molecule, Antibody, ADC, Biosimilar
- Species and models
- animal cell culture facilities, cell lines
- Assays and studies
- analytical method development, physicochemical characterization, biological characterization, similarity study, stability study, mechanism of action study, bioanalytical method development
- Instruments and platforms
- prefilled syringe (PFS) production facility
- Scale and capacity
- Songdo campus production capacity of 250,000L, Branchburg plant biopharmaceutical production capacity of 66,000L, Songdo Plant 1: 100,000L, Songdo Plant 2: 90,000L, Songdo Plant 3: 60,000L, Branchburg Plant: 11,000L x 6 lines, PFS filling capacity up to 20.8 million syringes per year
- Therapeutic areas
- immunology, oncology, haematology, ophthalmology, endocrinology, chronic spontaneous urticaria, allergic asthma, chronic rhinosinusitis with nasal polyps, inflammatory bowel disease, metastatic colorectal cancer, breast cancer
- Type
- CRDMO
- Sites
- Incheon, South Korea · Songdo, South Korea · Cheongju, South Korea
- Quality
- US FDA cGMP (all facilities) · Europe EMA cGMP (all facilities) · FDA cGMP-certified animal cell culture f (Songdo)
- Serves
- North America, Europe, Asia, South America, global
Public records
Similar labs. Hope Medicine (HopeMed), Sai Life, Transcenta Holding, Veloxity Labs
Found in a contract services directory. Listing built from celltrion.com. Work here? Claim this listing.